Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.292 SEK | -2.01% | 0.00% | +14.06% |
Mar. 26 | InDex Pharmaceuticals CEO, CFO to Step Down as Operations Cease | MT |
Mar. 26 | Index Pharmaceuticals Holding AB Announces Resignation of Johan Giléus as Deputy CEO | CI |
Sales 2023 | 97.5M 9.12M | Sales 2024 * | - | Capitalization | 156M 14.54M |
---|---|---|---|---|---|
Net income 2023 | -95M -8.88M | Net income 2024 * | -259M -24.22M | EV / Sales 2023 | 1.4 x |
Net cash position 2023 * | 171M 16.01M | Net Debt 2024 * | 86.32M 8.07M | EV / Sales 2024 * | - |
P/E ratio 2023 |
-1.42
x | P/E ratio 2024 * |
-0.61
x | Employees | 7 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 62.47% |
1 day | -2.01% | ||
Current month | +5.80% | ||
1 month | +4.66% | ||
3 months | +18.22% | ||
6 months | -60.96% | ||
Current year | +14.06% |
Managers | Title | Age | Since |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 22-12-31 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 17-04-30 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 15-12-31 |
Director/Board Member | 68 | 10-12-31 | |
Chairman | 72 | 10-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.292 | -2.01% | 1 045 340 |
24-03-27 | 0.298 | -1.32% | 2,613,222 |
24-03-26 | 0.302 | +1.68% | 4,326,865 |
24-03-25 | 0.297 | +2.41% | 2,511,495 |
24-03-22 | 0.29 | 0.00% | 3,639,663 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:48 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.06% | 14.95M | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |